Key facts
- This page summarizes Brian Philippe Tinmouth's Form 4 filing for PARDES BIOSCIENCES, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Sep 2022, 16:16.
Brian Philippe Tinmouth - 14 Sep 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.
- Reporting relationship
- Chief Bus. & Strategy Officer
- Issuer ticker
- N/A
- Reported as of
- 14 Sep 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Sep 2022, 16:16:05 UTC
- Prior SEC filing
- 22 Jun 2022
- Next SEC filing
- 20 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Lacy, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian Philippe Tinmouth filed Form 4 for PARDES BIOSCIENCES, INC. on 16 Sep 2022.
Change
- Previous filing in this sequence was filed on 22 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PRDS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +125,000
- Change %
- Price
- $0.000000
- Shares after
- 125,000
- Date
- 14 Sep 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 125,000
- Exercise price
- $2.98
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Options vest over two years with 1/2 of the shares subject to such option vesting and becoming exercisable on September 14, 2023, and the remaining 1/2 of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 14th day of each month thereafter, subject to continued service relationship.